All Stories

  1. Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes

    Article • Journal of Personalized Medicine, August 2026, MDPI AG

    Dr Emiliano Antiga

  2. Posidonia oceanica (L.) Delile as a Marine Anti-Inflammatory Modulator of Keratinocyte Inflammatory Responses Relevant to Psoriasis

    Article • Marine Drugs, February 2026, MDPI AG

    Dr Emiliano Antiga

  3. Optimizing Local Treatment in Pemphigus and Pemphigoid: Current Evidence and Unmet Needs

    Article • International Journal of Dermatology, February 2026, Wiley

    Dr Emiliano Antiga

  4. <em>Posidonia oceanica</em> (<em>L.</em>) <em>Delile</em> as a Marine Anti-Inflammatory Modulator of Keratinocyte Psoriatic Inflammation

    Article • February 2026, MDPI AG

    Dr Emiliano Antiga

  5. A Specific Signature of Circulating Free Fatty Acid Discriminates Bullous Pemphigoid From Pemphigus Vulgaris and Healthy Controls

    Article • Experimental Dermatology, February 2026, Wiley

    Dr Emiliano Antiga

  6. Peptide epitopes of NC16A BP180 in the diagnostics of bullous pemphigoid.

    Article • JID Innovations, September 2025, Elsevier

    Dr Emiliano Antiga

  7. The Role of Microbiota in the Pathogenesis of Bullous Pemphigoid and Pemphigus Vulgaris: Evidence, Controversies, and Perspectives

    Article • International Journal of Molecular Sciences, June 2025, MDPI AG

    Dr Emiliano Antiga

  8. Medical Nutrition Therapy in Dermatological Diseases: A Joint Consensus Statement of the Italian Association of Dietetics and Clinical Nutrition (ADI), the Italian Society of Dermatology and Sexually Transmitted Diseases (SIDeMaST), the Italian Society...

    Article • Current Obesity Reports, May 2025, Springer Science + Business Media

    Dr Emiliano Antiga

  9. Exploring the Gut Microbiota–Retina Axis: Implications for Health and Disease

    Article • Microorganisms, May 2025, MDPI AG

    Dr Emiliano Antiga, Elisabetta Rovida

  10. Off-label use of tralokinumab in the treatment of bullous pemphigoid: a case series

    Article • British Journal of Dermatology, January 2025, Oxford University Press (OUP)

    Dr Emiliano Antiga

  11. Management of Bullous Pemphigoid in Special Populations: A Narrative Review of the Literature

    Article • Dermatologic Therapy, January 2025, Wiley

    Dr Emiliano Antiga

  12. It is time to reconsider antibodies against integrin β4 in mucous membrane pemphigoid: Comment on ‘Native collagen XVII complex ELISA: An approach for diagnosis and monitoring of anti‐integrin β4 mucous membrane pemphigoid’

    Article • Journal of the European Academy of Dermatology and Venereology, June 2024, Wiley

    Dr Emiliano Antiga

  13. Posidonia oceanica (L.) Delile Is a Promising Marine Source Able to Alleviate Imiquimod-Induced Psoriatic Skin Inflammation

    Article • Marine Drugs, June 2024, MDPI AG

    Dr Emiliano Antiga

  14. S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and Venereology

    Article • Journal of the European Academy of Dermatology and Venereology, February 2024, Wiley

    Dr Emiliano Antiga

  15. Reply to ‘Comments on the first European guideline for paraneoplastic autoimmune multiorgan syndrome’

    Article • Journal of the European Academy of Dermatology and Venereology, February 2024, Wiley

    Dr Emiliano Antiga

  16. Hydroxychloroquine-induced generalized myopathy in a patient with lupus tumidus: a case report

    Article • Dermatology Reports, October 2023, PAGEPress Publications

    Dr Emiliano Antiga

  17. Impact of COVID‐19 in patients with autoimmune bullous diseases: Report from an international registry

    Article • Journal of the European Academy of Dermatology and Venereology, June 2023, Wiley

    Dr Emiliano Antiga

  18. Oral and Topical Probiotics and Postbiotics in Skincare and Dermatological Therapy: A Concise Review

    Article • Microorganisms, May 2023, MDPI AG

    Dr Emiliano Antiga

  19. Tralokinumab efficacy in a case of dupilumab‐resistant severe atopic dermatitis complicated by eczema herpeticum

    Article • Journal of the European Academy of Dermatology and Venereology, April 2023, Wiley

    Dr Emiliano Antiga

  20. S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology ( EADV )

    Article • Journal of the European Academy of Dermatology and Venereology, March 2023, Wiley

    Dr Emiliano Antiga

  21. Lepromatous leprosy presenting with erythema nodosum leprosum mimicking Bechet's disease

    Article • Travel Medicine and Infectious Disease, December 2022, Elsevier

    Dr Emiliano Antiga

  22. Severe bullous pemphigoid following Covid‐19 vaccination resistant to rituximab and successfully treated with dupilumab

    Article • Journal of the European Academy of Dermatology and Venereology, November 2022, Wiley

    Dr Emiliano Antiga

  23. Rituximab in Mucous Membrane Pemphigoid: A Monocentric Retrospective Study in 10 Patients with Severe/Refractory Disease

    Article • Journal of Clinical Medicine, July 2022, MDPI AG

    Dr Emiliano Antiga

  24. Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology ( EADV )

    Article • Journal of the European Academy of Dermatology and Venereology, June 2022, Wiley

    Dr Emiliano Antiga

  25. Sweet Syndrome Following SARS-CoV2 Vaccination

    Article • Vaccines, October 2021, MDPI AG

    Dr Emiliano Antiga

  26. Development and optimisation of biopharmaceutical properties of a new microemulgel of cannabidiol for locally-acting dermatological delivery

    Article • International Journal of Pharmaceutics, September 2021, Elsevier

    Dr Emiliano Antiga

  27. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV)

    Article • Journal of the European Academy of Dermatology and Venereology, May 2021, Wiley

    Dr Emiliano Antiga

  28. Dupilumab for the treatment of recalcitrant eosinophilic dermatosis of haematologic malignancy

    Article • Journal of the European Academy of Dermatology and Venereology, March 2021, Wiley

    Dr Emiliano Antiga

  29. The Role of TRPA1 in Skin Physiology and Pathology

    Article • International Journal of Molecular Sciences, March 2021, MDPI AG

    Dr Emiliano Antiga

  30. T-Cell Response in Dermatitis Herpetiformis: May Epidermal Transglutaminase Play a Role in Predicting Clinical Relapse?

    Article • Journal of Investigative Dermatology, December 2020, Elsevier

    Dr Emiliano Antiga

  31. Female Patients with Dermatitis Herpetiformis Show a Reduced Diagnostic Delay and Have Higher Sensitivity Rates at Autoantibody Testing for Celiac Disease

    Article • BioMed Research International, December 2019, Hindawi Publishing Corporation

    Dr Emiliano Antiga

  32. Cutaneous eruptions associated with haematologic malignancies: the need for a unifying nomenclature

    Article • Journal of the European Academy of Dermatology and Venereology, February 2019, Wiley

    Dr Emiliano Antiga

  33. Prevalence of Pruritus in Cutaneous Lupus Erythematosus: Brief Report of a Multicenter, Multinational Cross-Sectional Study

    Article • BioMed Research International, July 2018, Hindawi Publishing Corporation

    Dr Emiliano Antiga, Dr Hideo Hashizume, aminul islam, Professor Adam Reich, Professor Dr Mohammad Rafiqul Mowla

  34. T helper type 1-related molecules as well as interleukin-15 are hyperexpressed in the skin lesions of patients with pyoderma gangrenosum

    Article • Clinical & Experimental Immunology, June 2017, Wiley

    Dr Emiliano Antiga

  35. A fatal case of hidradenitis suppurativa associated with sepsis and squamous cell carcinoma

    Article • International Journal of Dermatology, October 2015, Wiley

    Dr Emiliano Antiga

  36. Docetaxel-induced-like subacute cutaneous lupus erythematosus

    Article • Clinical and Experimental Dermatology, September 2015, Wiley

    Dr Emiliano Antiga

  37. Corrigendum

    Article • Clinical & Experimental Immunology, June 2015, Wiley

    Dr Emiliano Antiga

  38. The Treg/Th17 cell ratio is reduced in the skin lesions of patients with pyoderma gangrenosum

    Article • British Journal of Dermatology, May 2015, Wiley

    Dr Emiliano Antiga

  39. The diagnosis and treatment of dermatitis herpetiformis

    Article • Clinical Cosmetic and Investigational Dermatology, May 2015, Dove Medical Press

    Dr Emiliano Antiga

  40. Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: the experience of the Italian immuno-pathology group

    Article • Journal of the European Academy of Dermatology and Venereology, March 2015, Wiley

    Dr Emiliano Antiga

  41. A case of rupioid psoriasis exacerbated by systemic glucocorticosteroids

    Article • International Journal of Dermatology, January 2015, Wiley

    Dr Emiliano Antiga

  42. Oral Curcumin (Meriva) Is Effective as an Adjuvant Treatment and Is Able to Reduce IL-22 Serum Levels in Patients with Psoriasis Vulgaris

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Dr Emiliano Antiga

  43. Regulatory T cells as well as IL-10 are reduced in the skin of patients with dermatitis herpetiformis

    Article • Journal of Dermatological Science, January 2015, Elsevier

    Dr Emiliano Antiga

  44. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome

    Article • Clinical & Experimental Immunology, September 2014, Wiley

    Dr Emiliano Antiga

  45. Dermatitis Herpetiformis: Not Only in Adults

    Article • Pediatric Dermatology, July 2014, Wiley

    Dr Emiliano Antiga

  46. Skin manifestations of celiac disease: not always dermatitis herpetiformis

    Article • International Journal of Dermatology, March 2014, Wiley

    Dr Emiliano Antiga

  47. Rowell syndrome: does it exist?

    Article • Clinical and Experimental Dermatology, June 2013, Wiley

    Dr Emiliano Antiga

  48. Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid

    Article • Journal of the European Academy of Dermatology and Venereology, January 2013, Wiley

    Dr Emiliano Antiga

  49. Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease — Dermatitis herpetiformis

    Article • Clinica Chimica Acta, January 2013, Elsevier

    Dr Emiliano Antiga

  50. Linear Immunoglobulin A Bullous Dermatosis: Need for an Agreement on Diagnostic Criteria

    Article • Dermatology, January 2013, Karger Publishers

    Dr Emiliano Antiga

  51. Cutaneous lupus erythematosus: First multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE)

    Article • Autoimmunity Reviews, January 2013, Elsevier

    Dr Emiliano Antiga, Professor Adam Reich

  52. A further case of subacute prurigo-like linear IgA bullous dermatosis: growing evidence of a new subset

    Article • International Journal of Dermatology, November 2012, Wiley

    Dr Emiliano Antiga

  53. Hailey-Hailey disease treated with methotrexate

    Article • Journal of Dermatological Case Reports, June 2012, Specjalisci Dermatolodzy

    Dr Emiliano Antiga

  54. Etanercept Downregulates the Th17 Pathway and Decreases the IL-17+/IL-10+ Cell Ratio in Patients with Psoriasis Vulgaris

    Article • Journal of Clinical Immunology, June 2012, Springer Science + Business Media

    Dr Emiliano Antiga

  55. Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients

    Article • Archives of Dermatological Research, February 2012, Springer Science + Business Media

    Dr Emiliano Antiga

  56. Newly Described Clinical and Immunopathological Feature of Dermatitis Herpetiformis

    Article • Clinical and Developmental Immunology, January 2012, Hindawi Publishing Corporation

    Dr Emiliano Antiga

  57. Dermatitis herpetiformis: Novel advances and hypotheses

    Article • World Journal of Dermatology, January 2012, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Emiliano Antiga

  58. Dermatitis Herpetiformis: From the Genetics to the Development of Skin Lesions

    Article • Clinical and Developmental Immunology, January 2012, Hindawi Publishing Corporation

    Dr Emiliano Antiga

  59. Celiac Disease and Dermatologic Manifestations: Many Skin Clue to Unfold Gluten-Sensitive Enteropathy

    Article • Gastroenterology Research and Practice, January 2012, Hindawi Publishing Corporation

    Dr Emiliano Antiga

  60. The last word on the so-called ‘Rowell’s syndrome’?

    Article • Lupus, December 2011, SAGE Publications

    Dr Emiliano Antiga

  61. Gluten-Free Diet in Patients With Dermatitis Herpetiformis: Not Only a Matter of Skin

    Article • Archives of Dermatology, August 2011, American Medical Association (AMA)

    Dr Emiliano Antiga

  62. Comment on "Dermatitis Herpetiformis Sera or Goat Anti-Transglutaminase-3 Transferred to Human Skin-Grafted Mice Mimics Dermatitis Herpetiformis Immunopathology"

    Article • The Journal of Immunology, July 2011, The American Association of Immunologists

    Dr Emiliano Antiga

  63. A case of lichenoid drug eruption associated with subcutaneous immunoglobulin therapy

    Article • Clinical Immunology, May 2011, Elsevier

    Dr Emiliano Antiga

  64. Serum levels of the regulatory cytokines transforming growth factor-β and interleukin-10 are reduced in patients with discoid lupus erythematosus

    Article • Lupus, March 2011, SAGE Publications

    Dr Emiliano Antiga

  65. Repigmentation of hair after latanoprost therapy

    Article • Journal of the European Academy of Dermatology and Venereology, December 2010, Wiley

    Dr Emiliano Antiga

  66. Characterization of regulatory T cells in patients with dermatomyositis

    Article • Journal of Autoimmunity, December 2010, Elsevier

    Dr Emiliano Antiga

  67. Effects of tacrolimus ointment on Toll-like receptors in atopic dermatitis

    Article • Clinical and Experimental Dermatology, November 2010, Wiley

    Dr Emiliano Antiga

  68. Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea

    Article • British Journal of Dermatology, May 2010, Wiley

    Dr Emiliano Antiga

  69. Immunosuppressive therapy may affect the number of circulating regulatory cells in systemic sclerosis: Pay attention to the patient selection criteria

    Article • Cellular Immunology, January 2010, Elsevier

    Dr Emiliano Antiga

  70. Linear immunoglobulin A bullous dermatosis

    Article • Expert Review of Dermatology, October 2009, Taylor & Francis

    Dr Emiliano Antiga

  71. Plasma levels of metalloproteinase-9 are elevated in patients with chronic autoimmune urticaria

    Article • British Journal of Dermatology, September 2009, Wiley

    Dr Emiliano Antiga

  72. Antilaminin-1 antibodies in cutaneous lupus erythematosus patients

    Article • Lupus, July 2009, SAGE Publications

    Dr Emiliano Antiga

  73. Guidelines for the diagnosis and treatment of dermatitis herpetiformis

    Article • Journal of the European Academy of Dermatology and Venereology, June 2009, Wiley

    Dr Emiliano Antiga

  74. A case of natural killer cell monoclonal expansion during efalizumab treatment in a patient with psoriasis

    Article • British Journal of Dermatology, April 2009, Wiley

    Dr Emiliano Antiga

  75. Serum Levels of IL-17 and IL-22 Are Reduced by Etanercept, but not by Acitretin, in Patients with Psoriasis: a Randomized-Controlled Trial

    Article • Journal of Clinical Immunology, September 2008, Springer Science + Business Media

    Dr Emiliano Antiga

  76. Serum interleukin-13 levels are increased in patients with Stevens–Johnson syndrome/ toxic epidermal necrolysis but not in those with erythema multiforme

    Article • British Journal of Dermatology, October 2007, Wiley

    Dr Emiliano Antiga

  77. FoxP3-expressing T regulatory cells in atopic dermatitis lesions

    Article • Allergy and Asthma Proceedings, September 2007, Oceanside Publications Inc.

    Dr Emiliano Antiga

  78. The CD40/CD40 ligand system is involved in the pathogenesis of pemphigus

    Article • Clinical Immunology, July 2007, Elsevier

    Dr Emiliano Antiga

  79. Chronic autoimmune urticaria in a patient with multiple piloleiomyomas

    Article • Clinical and Experimental Dermatology, July 2007, Wiley

    Dr Emiliano Antiga

  80. Cutis marmorata telangiectatica congenita and chronic autoimmune urticaria in a young man

    Article • The Journal of Dermatology, March 2007, Wiley

    Dr Emiliano Antiga

  81. The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: an immunohistochemical study

    Article • British Journal of Dermatology, February 2007, Wiley

    Dr Emiliano Antiga

  82. Serum Levels of the Th1 Promoter IL-12 and the Th2 Chemokine TARC Are Elevated in Erythema Multiforme and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Correlate with Soluble Fas Ligand Expression

    Article • Dermatology, January 2007, Karger Publishers

    Dr Emiliano Antiga

  83. Bullous pemphigoid initially localized around a urostomy

    Article • International Journal of Dermatology, November 2006, Wiley

    Dr Emiliano Antiga

  84. Expression of adhesion molecules in atopic dermatitis is reduced by tacrolimus, but not by hydrocortisone butyrate: a randomized immunohistochemical study

    Article • Clinical and Experimental Dermatology, November 2006, Wiley

    Dr Emiliano Antiga

  85. An unusual cause of gastrointestinal bleeding in a young girl

    Article • Canadian Medical Association Journal, September 2006, Canadian Medical Association (CMA)

    Dr Emiliano Antiga

  86. Ulcerative Carcinoma of the Breast With Zosteriform Skin Metastases

    Article • The Breast Journal, July 2006, Wiley

    Dr Emiliano Antiga

  87. The Effects of Tacrolimus Ointment on Regulatory T Lymphocytes in Atopic Dermatitis

    Article • Journal of Clinical Immunology, June 2006, Springer Science + Business Media

    Dr Emiliano Antiga

  88. Elevated circulating CD40 ligand in patients with erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum

    Article • British Journal of Dermatology, May 2006, Wiley

    Dr Emiliano Antiga

  89. A Case of Nodular Scleroderma

    Article • The Journal of Dermatology, December 2005, Wiley

    Dr Emiliano Antiga

  90. A Case of Lichenoid Drug Eruption Associated with Sildenafil Citratus

    Article • The Journal of Dermatology, December 2005, Wiley

    Dr Emiliano Antiga

  91. Radiation Therapy as a Trigger Factor for Initially Localized Bullous Pemphigoid

    Article • The Breast Journal, November 2005, Wiley

    Dr Emiliano Antiga

  92. Serological detection of eotaxin, IL-4, IL-13, IFN-γ, MIP-1α, TARC and IP-10 in chronic autoimmune urticaria and chronic idiopathic urticaria

    Article • Journal of Dermatological Science, October 2004, Elsevier

    Dr Emiliano Antiga

  93. Chronic Idiopathic and Chronic Autoimmune Urticaria: Clinical and Immunopathological Features of 68 Subjects

    Article • Acta Dermato-Venereologica, July 2004, Acta Dermato-Venereologica

    Dr Emiliano Antiga

  94. Dermatite atopica: diagnostica in vitro

    Article • Springer Science + Business Media

    Dr Emiliano Antiga